glp 1 needles Decoding GLP-1 Weight Loss Medications How to Read Needles/Syringes for

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D2

Supports healthy blood sugar metabolism*

Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors

A simplified graphic demonstrating the differences between endogenous and exogenous GLP-1

#PharmaBD #PharmaStrategy #GLP1 #Obesity #PharmaDeals #DrugDevelopment #Pfizer

Learn about Farxiga side effects, from common ones like increased urination to more serious